CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
Curis, Inc.
Curis, Inc.
Orca Biosystems, Inc.
Cellectar Biosciences, Inc.
Center for International Blood and Marrow Transplant Research
Center for International Blood and Marrow Transplant Research
UNC Lineberger Comprehensive Cancer Center
ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA)
Amgen
Kyowa Kirin Co., Ltd.
AO GENERIUM
Intellia Therapeutics
Celgene
Takeda
Swiss Pediatric Oncology Group
University of North Carolina, Chapel Hill
Amgen Research (Munich) GmbH
Amgen Research (Munich) GmbH
Ariad Pharmaceuticals